GLP1R and obesity due to melanocortin 4 receptor deficiency: One advantage of the GLP-1 receptor agonists in relation to obesity is that they play a significant role in inducing insulin secretion after meals and aid in weight loss by encouraging satiety and delaying stomach emptying [11-13].